Improved therapeutic targeting of the androgen receptor: rational drug design improves survival in castration-resistant prostate cancer
A Chiin Lim, G Attard - Current Drug Targets, 2013 - ingentaconnect.com
The growth and dependence of Prostate Cancer (PCa) on androgen stimulation led to the
use of castration to reduce circulating levels of androgens and anti-androgens to directly …
use of castration to reduce circulating levels of androgens and anti-androgens to directly …
Improved therapeutic targeting of the androgen receptor: rational drug design improves survival in castration-resistant prostate cancer.
AC Lim, G Attard - Current Drug Targets, 2013 - europepmc.org
The growth and dependence of Prostate Cancer (PCa) on androgen stimulation led to the
use of castration to reduce circulating levels of androgens and anti-androgens to directly …
use of castration to reduce circulating levels of androgens and anti-androgens to directly …
Improved therapeutic targeting of the androgen receptor: rational drug design improves survival in castration-resistant prostate cancer
AC Lim, G Attard - Current drug targets, 2013 - pubmed.ncbi.nlm.nih.gov
The growth and dependence of Prostate Cancer (PCa) on androgen stimulation led to the
use of castration to reduce circulating levels of androgens and anti-androgens to directly …
use of castration to reduce circulating levels of androgens and anti-androgens to directly …
Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer
AC Lim, G Attard - Current Drug Targets, 2013 - hero.epa.gov
The growth and dependence of Prostate Cancer (PCa) on androgen stimulation led to the
use of castration to reduce circulating levels of androgens and anti-androgens to directly …
use of castration to reduce circulating levels of androgens and anti-androgens to directly …